Abstract:Milbemycins A3/A4 are important 16-membered macrolides which have been commercialized and widely used as pesticide and veterinary medicine. However, similar to other milbemycin producers, the production of milbemycins A3/A4 in Streptomyces bingchenggensis is usually accompanied with undesired by-products such as C5-O-methylmilbemycins B2/B3 (α-class) and β1/β2 (β-class) together with nanchangmycin. In order to obtain high yield milbemycins A3/A4-producing strains that produce milbemycins A3/A4 as main components, milD, a putative C5-O-methyltransferase gene of S. bingchenggensis, was biofunctionally investigated by heterologous expression in Escherichia coli. Enzymatic analysis indicated that MilD can catalyze both α-class (A3/A4) and β-class milbemycins (β11) into C5-O-methylmilbemycins B2/B3 and β1, respectively, suggesting little effect of furan ring formed between C6 and C8a on the C5-O-methylation catalyzed by MilD. Deletion of milD gene resulted in the elimination of C5-O-methylmilbemycins B2/B3 and β1/β2 together with an increased yield of milbemycins A3/A4 in disruption strain BCJ13. Further disruption of the gene nanLD encoding loading module of polyketide synthase responsible for the biosynthesis of nanchangmycin led to strain BCJ36 that abolished the production of nanchangmycin. Importantly, mutant strain BCJ36 (∆milD∆nanLD) produced milbemycins A3/A4 as main secondary metabolites with a yield of 2312 ± 47 μg/ml, which was approximately 74 % higher than that of the initial strain S. bingchenggensis BC-109-6 (1326 ± 37 μg/ml).

New Milbemycin Metabolites from the Genetically Engineered Strain Streptomyces Bingchenggensis Bcj60

Two New Milbemycin Derivatives from a Genetically Engineered Strain Streptomyces Bingchenggensis.

Two New 5-Oxomilbemycins Possessing an Unusual 3,27-Epoxy Bond from the Genetically Engineered Strain Streptomyces Bingchenggensis BCJ60

New Macrocyclic Lactones with Acaricidal and Nematocidal Activities from a Genetically Engineered Strain Streptomyces Bingchenggensis BCJ60

New 5-Oxomilbemycins from A Genetically Engineered Strain Streptomyces Bingchenggensis Bcj60

A Novel Spiro-Heterocycle Milbemycin Metabolite from a Genetically Engineered Strain of Streptomyces Bingchenggensis.

Further new milbemycin antibiotics from Streptomyces bingchenggensis. Fermentation, isolation, structural elucidation and biological activities.

Two New 13-Hydroxylated Milbemycin Metabolites from the Genetically Engineered Strain Streptomyces Avermitilis AVE-H39

Two novel milbemycin derivatives from the genetically engineered strain Streptomyces avermitilis AVE-H39

Two New Β-Class Milbemycins from Streptomyces Bingchenggensis: Fermentation, Isolation, Structure Elucidation and Biological Properties

Three new milbemycin derivatives from Streptomyces bingchenggensis.

Three new milbemycins from a genetically engineered strain S . avermitilis MHJ1011

Three New 16-Membered Macrolide Compounds from a Genetically Engineered Strain S. Avermitilis MHJ1011.

Design, Synthesis, and Biological Activities of Milbemycin Analogues

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Synthesis, Characterization and Insecticidal Activity of Milbemycin Analogues

New Milbemycins from Mutant Streptomyces Bingchenggensis X-4

Genetic Engineering of Streptomyces Bingchenggensis to Produce Milbemycins A3/A4 As Main Components and Eliminate the Biosynthesis of Nanchangmycin

Characterization of a Pathway-Specific Activator of Milbemycin Biosynthesis and Improved Milbemycin Production by Its Overexpression in Streptomyces Bingchenggensis

Recent Advances of Natural Product Pesticide Milbemycins from Streptomyces

Two New 13-Oxomilbemycins from a NTG-Induced Mutation Strain of Streptomyces Avermitilis AVE-H39